HomeStock ScreenerRossari BiotechQuarterly Results

Rossari Biotech Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹46 Cr
QMar 2026
Quarterly Results

In Mar 2026, Rossari Biotech (ROSSARI) reported revenue ₹704 Cr and net profit ₹46 Cr — revenue +21.0% YoY. Also explore ROSSARI share price charts to track price trends across different timeframes.

ROSSARI Quarterly Results — Revenue, Profit & EPS Highlights

Rossari Biotech latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Browse ROSSARI annual financials for revenue, profit, balance sheet and cash flow data.

  • Revenue of ₹704 Cr in Mar 2026 (+0.4% vs Jun 2026, +21.0% vs Mar 2025)
  • Net Profit of ₹46 Cr in Mar 2026 (+31.4% vs Jun 2026, +35.3% vs Mar 2025)
  • EBITDA of ₹97 Cr in Mar 2026 (+15.5% vs Jun 2026)
  • Operating Margin of 11.0% in Mar 2026 (-1.0pp vs Jun 2026)
  • Earnings Per Share of ₹8.30 in Mar 2026 (+30.9% vs Jun 2026)

Rossari Biotech Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ROSSARI quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 704 701 588 582 545 0.4% 21.0%
Net Profit (₹ Cr) 46 35 37 34 34 - -
EBITDA (₹ Cr) 97 84 74 71 70 - -
EPS (₹) 8.30 6.34 6.66 6.22 6.07 - -
Operating Margin (%) 11.0% 12.0% 12.0% 12.0% 12.0% - -

ROSSARI Share Price Trend — 1-Year Movement Across Quarterly Results

Rossari Biotech 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Rossari Biotech share price today.

Profitability Ratios

Profit Margin 6.5%
EBITDA Margin 13.8%
Operating Margin 11.0%
ROE (Annual) 13.8%

Balance Sheet Highlights

Total Assets ₹2,289 Cr
Total Equity ₹1,333 Cr
Current Assets ₹1,236 Cr
Current Liabilities ₹166 Cr

Cash Flow Analysis

Operating Cash Flow ₹65 Cr
Investing Cash Flow ₹-220 Cr
Financing Cash Flow ₹186 Cr
Net Cash Flow ₹31 Cr

Current Market Data

Current Price ₹489.80
Exchange NSE
Last Updated Jul 24, 2026

ROSSARI vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap

Rossari Biotech latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Pidilite Industries
Mar 2026
₹163,719.34 Cr 1570.9 3,648 584 +1.2% +13.2% 16.0% 276.1
SRF
Mar 2026
₹81,872.54 Cr 2664.7 4,557 582 +28.0% +7.2% 12.8% 135.7
Coromandel Internat…
Mar 2026
₹60,014.83 Cr 1980.8 6,068 115 -37.9% +11.1% 1.9% 417.0
Linde
Mar 2026
₹59,771.45 Cr 6731.0 621 77 -4.5% +2.6% 12.4% 741.3
Fertilisers & Chemi…
Sept 2025
₹52,674.89 Cr 809.3 1,681 21 +48.8% - 1.2% 2529.1
Sector Quarterly Performance Comparison
Chemicals sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores